绘制标准曲线:在Excel工作表中,以标准品浓度作横坐标,对应OD值作纵坐标,绘制出标准品线性回归曲线,按曲线方程计算各样本浓度值。

参数:灵敏度100%;特异度96%;假阳性率3%;假阴性率0;确度 99%;售前:为客户提供全面技术咨询服务,任何咨询都会细心答复,无论购买与否,您的咨询都是一次缘分的邂逅。
凡购买
牛血清白蛋白(BSA)ELisa定量检测试剂盒相关人、大小鼠、兔、羊、猴、猪、豚鼠ELISA试剂盒等种属ELISA试剂盒产品,我司提供免费代测,需要代测单位的试验材料和试剂等均须采用特快专递形式邮寄,有低温要求的、固定要求的,按低温保存、固定防碎方法运输,以确保实验物品的安全可靠。如数量巨大,我司可以让专业人员前往提取样本。详情请与我司销售人员联系。
Recombinant Transferrin Receptor 2 (TFR2)转铁蛋白受体2(TFR2)重组蛋白
Native Transferrin Receptor (TFR) 转铁蛋白受体(TFR)天然蛋白
Recombinant Transthyretin (TTR)转甲状腺素蛋白(TTR)重组蛋白
Recombinant Transformer 2 Beta (TRA2b)转化因子2β(TRA2β)重组蛋白
Recombinant Transforming Growth Factor Beta Induced Protein (TGFbI)转化生长因子β诱导蛋白(TGFβI)重组蛋白
Recombinant Transforming Growth Factor Beta Receptor I (TGFbR1)转化生长因子β受体Ⅰ(TGFβR1)重组蛋白
Recombinant Transforming Growth Factor Beta 1 (TGFb1)转化生长因子β1(TGFβ1)重组蛋白
Recombinant Latrophilin 3 (LPHN3)蛛毒素受体3(LPHN3)重组蛋白
Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)周期素依赖性激酶抑制因子2A(CDKN2A)重组蛋白
Recombinant Cyclin Dependent Kinase 5 (CDK5)周期素依赖性激酶5(CDK5)重组蛋白
Recombinant Cyclin Dependent Kinase 4 (CDK4)周期素依赖性激酶4(CDK4)重组蛋白
Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)肿瘤坏死因子相关凋亡诱导配体(TRAIL)重组蛋白
Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 7 (TNFSF7)肿瘤坏死因子配体超家族成员7(TNFSF7)重组蛋白BIX01294 (hydrochloride hydrate) (50 mg)2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine, trihydrochloride, hydrate; BIX01294 (hydrochloride hydrate)
GW 4869 (hydrochloride hydrate) (1 mg)3,3’-(1,4-phenylene)bis[N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-dihydrochloride-2-propenamide; GW 4869 (hydrochloride hydrate)
GW 4869 (hydrochloride hydrate) (10 mg)3,3’-(1,4-phenylene)bis[N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-dihydrochloride-2-propenamide; GW 4869 (hydrochloride hydrate)
GW 4869 (hydrochloride hydrate) (5 mg)3,3’-(1,4-phenylene)bis[N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-dihydrochloride-2-propenamide; GW 4869 (hydrochloride hydrate)
牛血清白蛋白(BSA)ELisa定量检测试剂盒GW 4869 (hydrochloride hydrate) (500 ug)3,3’-(1,4-phenylene)bis[N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-dihydrochloride-2-propenamide; GW 4869 (hydrochloride hydrate)
trans-trismethoxy Resveratrol-d4 (100 ug)1,3-dimethoxy-5-[(1E)-2-(4-methoxyphenyl)ethenyl]-benzene-2,3,5,6-d4; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4; trans-trismethoxy Resveratrol-d4
trans-trismethoxy Resveratrol-d4 (250 ug)1,3-dimethoxy-5-[(1E)-2-(4-methoxyphenyl)ethenyl]-benzene-2,3,5,6-d4; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4; trans-trismethoxy Resveratrol-d4